GSK plc - Insider Trading & Ownership

Entity
Company
Location
79 New Oxford Street, London, United Kingdom
Summary
The estimated value of insider holdings of GSK plc is at least $234M dollars as of October 1, 2024. GSK plc is the 10%+ Owner of Wave Life Sciences Ltd. and owns shares of Wave Life Sciences Ltd. (WVE) stock worth about $134M. GSK plc is the 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $69M. GSK plc is the 10%+ Owner of CVRx, Inc. and owns shares of CVRx, Inc. (CVRX) stock worth about $18.7M. GSK plc is the 10%+ Owner of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $11.7M.
All Insider Reports
All Insider Reports

Ownership of GSK plc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
WVE Wave Life Sciences Ltd. 10%+ Owner $134M +$38.8M +40.7% Sep 27, 2024
LYEL Lyell Immunopharma, Inc. 10%+ Owner $69M Jun 21, 2021
CVRX CVRx, Inc. 10%+ Owner $18.7M Jul 2, 2021
SPRO Spero Therapeutics, Inc. 10%+ Owner $11.7M Nov 7, 2022
ME 23andMe Holding Co. 10%+ Owner Jun 16, 2021
INVA Innoviva, Inc. 10%+ Owner May 20, 2021
TBPH Theravance Biopharma, Inc. Former 10% Owner Sep 16, 2022

Insider Transactions Reported by GSK plc:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.